Teresa DeLuca's most recent trade in LifeStance Health Group Inc was a trade of 35,211 Common Stock done . Disclosure was reported to the exchange on Aug. 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
LifeStance Health Group Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 35,211 | 71,574 | - | 0 | Common Stock | |
LifeStance Health Group Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2024 | 36,363 | 36,363 | - | 0 | Common Stock | |
Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 25.93 per share. | 06 Jun 2024 | 6,170 | 58,330 (0%) | 0% | 25.9 | 159,988 | Common Stock |
Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 38.16 per share. | 01 Jun 2023 | 4,192 | 52,160 (0%) | 0% | 38.2 | 159,967 | Common Stock |
Surgery Partners Inc | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 24.50 per share. | 21 Nov 2022 | 20,000 | 47,968 (0%) | 0% | 24.5 | 490,000 | Common Stock |
Surgery Partners Inc | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 39.70 per share. | 20 May 2022 | 4,030 | 27,968 (0%) | 0% | 39.7 | 159,991 | Common Stock |
180 Life Sciences Corp | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 21,000 | 21,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Surgery Partners Inc | Teresa M. DeLuca | Director | Sale of securities on an exchange or to another person at price $ 53.50 per share. | 24 Mar 2022 | 1,535 | 23,938 (0%) | 0% | 53.5 | 82,123 | Common Stock |
180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 09 Dec 2021 | 5,000 | 5,000 | - | 4 | 20,000 | Common Stock |
180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 09 Dec 2021 | 2,500 | 2,500 | - | 4.0 | 9,975 | Common Stock |
180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 09 Dec 2021 | 2,500 | 2,500 | - | 4.0 | 9,950 | Common Stock |
180 Life Sciences Corp | Teresa M. DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 3.95 per share. | 09 Dec 2021 | 2,500 | 2,500 | - | 4.0 | 9,875 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Purchase of securities on an exchange or from another person at price $ 46.70 per share. | 10 Aug 2021 | 2,000 | 25,473 (0%) | 0% | 46.7 | 93,400 | Common Stock |
180 Life Sciences Corp | Teresa M. DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 79,000 | 79,000 | - | - | Non-Qualified Stock Option (right to buy) | |
Surgery Partners Inc | Teresa DeLuca | Director | Sale of securities on an exchange or to another person at price $ 63.67 per share. | 09 Jun 2021 | 5,035 | 23,473 (0%) | 0% | 63.7 | 320,578 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Sale of securities on an exchange or to another person at price $ 63.05 per share. | 08 Jun 2021 | 2,633 | 28,508 (0%) | 0% | 63.1 | 166,011 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 3,330 | 31,141 (0%) | 0% | 0 | Common Stock | |
Surgery Partners Inc | Teresa DeLuca | Director | Sale of securities on an exchange or to another person at price $ 27.15 per share. | 14 Dec 2020 | 1,000 | 27,811 (0%) | 0% | 27.2 | 27,150 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Sale of securities on an exchange or to another person at price $ 27.75 per share. | 04 Dec 2020 | 915 | 28,811 (0%) | 0% | 27.7 | 25,391 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.24 per share. | 01 Dec 2020 | 4,199 | 33,010 (0%) | 0% | 20.2 | 84,988 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 4,199 | 0 | - | - | Stock Option (Right to Buy) | |
Surgery Partners Inc | Teresa DeLuca | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.88 per share. | 01 Dec 2020 | 3,284 | 29,726 (0%) | 0% | 25.9 | 84,990 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 10 Sep 2020 | 3,000 | 28,811 (0%) | 0% | 21 | 63,000 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Sale of securities on an exchange or to another person at price $ 20.60 per share. | 10 Aug 2020 | 5,317 | 31,811 (0%) | 0% | 20.6 | 109,530 | Common Stock |
Surgery Partners Inc | Teresa DeLuca | Director | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 27 May 2020 | 9,669 | 37,128 (0%) | 0% | 14.5 | 140,007 | Common Stock |